Skip to main content

Metabolon, Syngenta Expand AgBio Pact

NEW YORK (GenomeWeb News) – Metabolon said today that it has expanded a multi-year agreement with Syngenta giving the agricultural products firm access to its biochemical profiling technology for use in agricultural products.
 
The agreement follows initial studies performed by Research Triangle Park, NC-based Metabolon for Syngenta to test the application of its technology. Syngenta will use the technology for making decisions on crop traits sooner in the development cycle.
 
“Metabolon’s technology provides us critical insights to the performance of our products, which will aid development of new offerings for our grower customers,” Roger Kemble, head of crop genetics research for Syngenta, said in a statement.
 
Financial terms of the alliance were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.